AAPL   319.32 (+0.33%)
MSFT   182.81 (+0.78%)
AMZN   2,412.06 (+0.46%)
NVDA   345.76 (+1.85%)
CGC   17.50 (-19.43%)
MU   47.13 (+1.42%)
GE   6.60 (-2.65%)
AMD   52.47 (+1.41%)
T   30.61 (-1.45%)
ACB   14.01 (-8.67%)
F   5.71 (-2.40%)
GILD   75.45 (+0.17%)
NFLX   415.06 (+0.39%)
BAC   24.44 (-1.69%)
AAPL   319.32 (+0.33%)
MSFT   182.81 (+0.78%)
AMZN   2,412.06 (+0.46%)
NVDA   345.76 (+1.85%)
CGC   17.50 (-19.43%)
MU   47.13 (+1.42%)
GE   6.60 (-2.65%)
AMD   52.47 (+1.41%)
T   30.61 (-1.45%)
ACB   14.01 (-8.67%)
F   5.71 (-2.40%)
GILD   75.45 (+0.17%)
NFLX   415.06 (+0.39%)
BAC   24.44 (-1.69%)
AAPL   319.32 (+0.33%)
MSFT   182.81 (+0.78%)
AMZN   2,412.06 (+0.46%)
NVDA   345.76 (+1.85%)
CGC   17.50 (-19.43%)
MU   47.13 (+1.42%)
GE   6.60 (-2.65%)
AMD   52.47 (+1.41%)
T   30.61 (-1.45%)
ACB   14.01 (-8.67%)
F   5.71 (-2.40%)
GILD   75.45 (+0.17%)
NFLX   415.06 (+0.39%)
BAC   24.44 (-1.69%)
AAPL   319.32 (+0.33%)
MSFT   182.81 (+0.78%)
AMZN   2,412.06 (+0.46%)
NVDA   345.76 (+1.85%)
CGC   17.50 (-19.43%)
MU   47.13 (+1.42%)
GE   6.60 (-2.65%)
AMD   52.47 (+1.41%)
T   30.61 (-1.45%)
ACB   14.01 (-8.67%)
F   5.71 (-2.40%)
GILD   75.45 (+0.17%)
NFLX   415.06 (+0.39%)
BAC   24.44 (-1.69%)
Log in

NASDAQ:ANGOAngioDynamics Stock Price, Forecast & News

$10.22
-0.28 (-2.67 %)
(As of 05/29/2020 02:49 PM ET)
Add
Compare
Today's Range
$9.93
Now: $10.22
$10.52
50-Day Range
$9.19
MA: $10.35
$11.27
52-Week Range
$7.48
Now: $10.22
$22.09
Volume110,247 shs
Average Volume222,662 shs
Market Capitalization$384.58 million
P/E Ratio7.90
Dividend YieldN/A
Beta0.71
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. It also offers thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. In addition, the company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; and Asclera injection for treating uncomplicated spider and reticular veins of the lower extremities. Further, it provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation system; and radiofrequency ablation products for ablating solid cancerous or benign tumors. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Read More
AngioDynamics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 3.8 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.04 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ANGO
CUSIP03475V10
Phone518-795-1400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$359.48 million
Cash Flow$1.45 per share
Book Value$16.52 per share

Profitability

Net Income$61.34 million

Miscellaneous

Employees1,050
Market Cap$384.58 million
Next Earnings Date7/8/2020 (Estimated)
OptionableOptionable

Receive ANGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter.

AngioDynamics (NASDAQ:ANGO) Frequently Asked Questions

How has AngioDynamics' stock been impacted by COVID-19 (Coronavirus)?

AngioDynamics' stock was trading at $10.14 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ANGO stock has increased by 0.6% and is now trading at $10.20. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of AngioDynamics?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AngioDynamics.

When is AngioDynamics' next earnings date?

AngioDynamics is scheduled to release its next quarterly earnings announcement on Wednesday, July 8th 2020. View our earnings forecast for AngioDynamics.

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) issued its earnings results on Tuesday, April, 7th. The medical instruments supplier reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.04. The medical instruments supplier had revenue of $69.80 million for the quarter, compared to analyst estimates of $68.55 million. AngioDynamics had a net margin of 16.27% and a return on equity of 2.49%. AngioDynamics's revenue was down 19.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.19 earnings per share. View AngioDynamics' earnings history.

What price target have analysts set for ANGO?

2 analysts have issued 1 year price targets for AngioDynamics' shares. Their forecasts range from $14.00 to $21.00. On average, they anticipate AngioDynamics' stock price to reach $17.50 in the next year. This suggests a possible upside of 71.6% from the stock's current price. View analysts' price targets for AngioDynamics.

Has AngioDynamics been receiving favorable news coverage?

News articles about ANGO stock have been trending negative on Friday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. AngioDynamics earned a media sentiment score of -2.4 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutAngioDynamics.

Are investors shorting AngioDynamics?

AngioDynamics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 959,600 shares, an increase of 12.1% from the March 31st total of 855,900 shares. Based on an average daily volume of 305,500 shares, the short-interest ratio is currently 3.1 days. Approximately 2.6% of the shares of the stock are short sold. View AngioDynamics' Current Options Chain.

Who are some of AngioDynamics' key competitors?

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include General Electric (GE), Oasis Petroleum (OAS), Intel (INTC), Ring Energy (REI), Ring Energy (REI), Bank of America (BAC), FireEye (FEYE), Hanesbrands (HBI), Mattel (MAT) and Marathon Oil (MRO).

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the following people:
  • Mr. James C. Clemmer, CEO, Pres & Director (Age 55)
  • Mr. Michael C. Greiner, Exec. VP & CFO (Age 46)
  • Mr. David D. Helsel, Sr. VP of Global Operations and R&D (Age 55)
  • Mr. Stephen A. Trowbridge, Sr. VP & Gen. Counsel (Age 45)
  • Mr. Robert A. Simpson, Sr. VP & GM of Vascular Interventions and Therapies (Age 47)

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

Who are AngioDynamics' major shareholders?

AngioDynamics' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.47%), Victory Capital Management Inc. (12.76%), Victory Capital Management Inc. (12.76%), State Street Corp (4.56%), Wells Fargo & Company MN (3.00%) and Janus Henderson Group PLC (2.02%). Company insiders that own AngioDynamics stock include James C Clemmer, Kevin J Gould and Michael Greiner. View institutional ownership trends for AngioDynamics.

Which institutional investors are selling AngioDynamics stock?

ANGO stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Morgan Stanley, BlackRock Inc., Two Sigma Investments LP, Russell Investments Group Ltd., SG Americas Securities LLC, Squarepoint Ops LLC, and WINTON GROUP Ltd. View insider buying and selling activity for AngioDynamics.

Which institutional investors are buying AngioDynamics stock?

ANGO stock was purchased by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Victory Capital Management Inc., Victory Capital Management Inc., State Street Corp, Systematic Financial Management LP, Wells Fargo & Company MN, Acadian Asset Management LLC, and Arnhold LLC. View insider buying and selling activity for AngioDynamics.

How do I buy shares of AngioDynamics?

Shares of ANGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AngioDynamics' stock price today?

One share of ANGO stock can currently be purchased for approximately $10.20.

How big of a company is AngioDynamics?

AngioDynamics has a market capitalization of $383.83 million and generates $359.48 million in revenue each year. The medical instruments supplier earns $61.34 million in net income (profit) each year or $0.83 on an earnings per share basis. AngioDynamics employs 1,050 workers across the globe.

What is AngioDynamics' official website?

The official website for AngioDynamics is www.angiodynamics.com.

How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The medical instruments supplier can be reached via phone at 518-795-1400 or via email at [email protected]

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.